Aortic arch atherosclerosis represents a specific and clinically significant manifestation of systemic atherosclerotic disease, denoting the buildup of lipid-rich plaque within the innermost layer of the large arterial arch that supplies blood to the head, neck, and upper extremities. This condition forms part of the broader spectrum of atherosclerosis, a chronic inflammatory process that affects medium and large arteries throughout the body, yet its location presents distinct diagnostic and therapeutic considerations. The accumulation of cholesterol, cellular debris, calcium, and fibrous tissue within the intima can gradually narrow the arterial lumen, compromising cerebral and upper limb perfusion, while the unstable nature of some plaques carries the risk of acute thrombotic complications.
Pathophysiology and Development
The pathophysiology of aortic arch atherosclerosis begins with endothelial dysfunction, often triggered by factors such as hypertension, hyperlipidemia, smoking, or diabetes. This dysfunction allows low-density lipoprotein (LDL) cholesterol to penetrate the arterial wall, where it undergoes oxidation and triggers a cascade of inflammatory responses. Immune cells, particularly monocytes, migrate into the intima, differentiate into macrophages, and engulf oxidized LDL, transforming into foam cells that form the fatty streak. Over time, a more complex lesion develops, featuring a fibrous cap, a necrotic lipid core, and ongoing inflammation, which can progressively encroach upon the vessel diameter.
Clinical Manifestations and Symptoms
The clinical presentation of aortic arch atherosclerosis is highly variable, ranging from being completely asymptomatic to causing significant, life-threatening complications. Symptoms primarily arise from two mechanisms: critical stenosis reducing blood flow and systemic embolization of plaque fragments. Reduced flow can manifest as dizziness, syncope, or claudication in the upper limbs, while embolization can lead to transient ischemic attacks (TIAs) or strokes, often affecting the contralateral hemisphere or brainstem. Physical examination may reveal diminished or asymmetric pulses in the carotid, subclavian, or vertebral territories.
Associated Conditions and Risk Factors
Individuals with aortic arch atherosclerosis frequently harbor concomitant disease in other vascular beds, reflecting the systemic nature of atherosclerosis. Coronary artery disease, peripheral arterial disease, and cerebrovascular disease are common comorbidities that significantly influence overall prognosis and management strategy. Key modifiable risk factors include cigarette smoking, dyslipidemia (elevated LDL, low HDL), hypertension, diabetes mellitus, obesity, and a sedentary lifestyle, while non-modifiable factors encompass advanced age, male sex, and a family history of premature cardiovascular disease.
Diagnostic Evaluation
Establishing the diagnosis and characterizing the aortic arch lesion requires a multimodal imaging approach, chosen based on clinical urgency, local expertise, and patient factors. Computed Tomography Angiography (CTA) is often the first-line test, offering high spatial resolution, rapid acquisition, and detailed anatomical mapping of the arch and its branches. Magnetic Resonance Angiography (MRA) provides excellent soft tissue contrast without ionizing radiation, though image quality can be limited by motion artifacts. For patients with contraindications to CTA or MRA, contrast-enhanced ultrasound and invasive angiography remain valuable alternatives, particularly for procedural planning.
Interpretation of Imaging Findings
Radiological interpretation focuses on delineating the location, severity, and morphology of the plaques. Critical stenosis is generally defined as a luminal diameter reduction of 50% or more, though clinical correlation is essential, as the hemodynamic significance depends on collateral circulation and the presence of symptoms. Imaging also assesses plaque characteristics, such as surface irregularity, ulceration, or the presence of a lipid-rich necrotic core, which are associated with a higher risk of embolization. The assessment often extends to evaluate the thoracic aorta for concomitant dilation or dissection.
